Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research Article

A Microarray Approach to Translational Medicine in Breast Cancer: How Representative are Cell Line Models of Clinical Conditions?

JAI PRAKASH MEHTA, LORRAINE O'DRISCOLL, NIALL BARRON, MARTIN CLYNES and PADRAIG DOOLAN
Anticancer Research May 2007, 27 (3A) 1295-1300;
JAI PRAKASH MEHTA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mehtaj2{at}mail.dcu.ie
LORRAINE O'DRISCOLL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NIALL BARRON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARTIN CLYNES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PADRAIG DOOLAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The aim of this study was to examine whether the degree to which cell lines model corresponding cells in vivo is an important aspect of their value as models in studying disease processes. Materials and Methods: The work presented here utilizes gene expression data from two published microarray datasets to compare the differences and similarities among the two systems in order to identify major transcriptional changes in the adaptation process from a tissue to a cell line. Results: Gene ontology and pathway analyses of comparator gene lists showed that the cell cycle related genes were significantly up-regulated in cell lines and immune response related genes were significantly up-regulated in clinical specimens. Estrogen receptor analysis also indicated differences in the clustering patterns of cell lines relative to clinical specimens. Conclusion: These findings suggest that significant differences in gene expression exist between clinical conditions and their respective cell line models and that these differences should be taken into account when extrapolating cell line results to in vivo systems.

  • Cell line
  • clinical specimens
  • cell cycle
  • immune response
  • representative model
  • estrogen receptor
  • hierarchical clustering
  • principal component analysis

Footnotes

  • Received December 19, 2006.
  • Revision received February 15, 2007.
  • Accepted February 16, 2007.
  • Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 27, Issue 3A
May-June 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Microarray Approach to Translational Medicine in Breast Cancer: How Representative are Cell Line Models of Clinical Conditions?
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
12 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
A Microarray Approach to Translational Medicine in Breast Cancer: How Representative are Cell Line Models of Clinical Conditions?
JAI PRAKASH MEHTA, LORRAINE O'DRISCOLL, NIALL BARRON, MARTIN CLYNES, PADRAIG DOOLAN
Anticancer Research May 2007, 27 (3A) 1295-1300;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
A Microarray Approach to Translational Medicine in Breast Cancer: How Representative are Cell Line Models of Clinical Conditions?
JAI PRAKASH MEHTA, LORRAINE O'DRISCOLL, NIALL BARRON, MARTIN CLYNES, PADRAIG DOOLAN
Anticancer Research May 2007, 27 (3A) 1295-1300;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Comparing cancer cell lines and tumor samples by genomic profiles
  • Google Scholar
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire